(+)-Styrene oxide

Danger

H312 (98.2%): Harmful in contact with skin [Warning Acute toxicity, dermal]；H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H350 (100%): May cause cancer [Danger Carcinogenicity]

P203, P264+P265, P280, P302+P352, P305+P351+P338, P317, P318, P321, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 57 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Chemical: Oxirane, phenyl-, (R)-

(R)-Styrene oxide: Does not have an individual approval but may be used under an appropriate group standard

IMAP assessments - Phenyloxirane and its isomers: Human health tier II assessment

Acute Tox. 4 (98.2%)；Eye Irrit. 2 (100%)；Carc. 1B (100%)

Acute toxicity - category 4；Eye irritation - category 2A；Skin sensitisation - category 1；Carcinogenicity - category 1B

Chemical: Oxirane, phenyl-, (R)-

(R)-Styrene oxide: Does not have an individual approval but may be used under an appropriate group standard

Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.

Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.